CLINICAL UTILITY OF QUALITY OF LIFE (QOL) AND SYMPTOM ASSESSMENT AS PROGNOSTIC FACTORS FOR SURVIVAL AND MEASURES OF TREATMENT EFFECTS ON RTOG 0525 Conference

Armstrong, Terri, Wefel, Jeffrey S, Wang, Meihua et al. (2011). CLINICAL UTILITY OF QUALITY OF LIFE (QOL) AND SYMPTOM ASSESSMENT AS PROGNOSTIC FACTORS FOR SURVIVAL AND MEASURES OF TREATMENT EFFECTS ON RTOG 0525 . NEURO-ONCOLOGY, 13 121-121.

International Collaboration

cited authors

  • Armstrong, Terri; Wefel, Jeffrey S; Wang, Meihua; Won, Minhee; Bottomley, Andrew; Mendoza, Tito R; Coens, Corneel; Werner-Wasik, Maria; Brachman, David G; Choucair, Ali K; Mehta, Minesh; Gilbert, Mark R

authors

publication date

  • November 1, 2011

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

publisher

  • OXFORD UNIV PRESS INC

start page

  • 121

end page

  • 121

volume

  • 13